Bogacz-Piaseczyńska, A.; Bożek, A.; Krupka-Olek, M.; Kawczyk-Krupka, A.; Zalejska-Fiolka, J.; Canonica, G.W.
Dupilumab and House Dust Mite Immunotherapy in Patients with Atopic Dermatitis: A Preliminary Study. Vaccines 2024, 12, 1046.
https://doi.org/10.3390/vaccines12091046
AMA Style
Bogacz-Piaseczyńska A, Bożek A, Krupka-Olek M, Kawczyk-Krupka A, Zalejska-Fiolka J, Canonica GW.
Dupilumab and House Dust Mite Immunotherapy in Patients with Atopic Dermatitis: A Preliminary Study. Vaccines. 2024; 12(9):1046.
https://doi.org/10.3390/vaccines12091046
Chicago/Turabian Style
Bogacz-Piaseczyńska, Agnieszka, Andrzej Bożek, Magdalena Krupka-Olek, Aleksandra Kawczyk-Krupka, Jolanta Zalejska-Fiolka, and Giorgio Walter Canonica.
2024. "Dupilumab and House Dust Mite Immunotherapy in Patients with Atopic Dermatitis: A Preliminary Study" Vaccines 12, no. 9: 1046.
https://doi.org/10.3390/vaccines12091046
APA Style
Bogacz-Piaseczyńska, A., Bożek, A., Krupka-Olek, M., Kawczyk-Krupka, A., Zalejska-Fiolka, J., & Canonica, G. W.
(2024). Dupilumab and House Dust Mite Immunotherapy in Patients with Atopic Dermatitis: A Preliminary Study. Vaccines, 12(9), 1046.
https://doi.org/10.3390/vaccines12091046
